Antiulcerant Drugs Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Antiulcerant Drugs Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Antiulcerant Drugs Market by Type: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Stomach Ulcers

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Leg Ulcers

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Peptic Ulcers

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.5  Esophageal Ulcers

4.5.1   Current Trend and Analysis

4.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.6  Bleeding Ulcer

4.6.1   Current Trend and Analysis

4.6.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.6.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.7  Refractory Ulcer

4.7.1   Current Trend and Analysis

4.7.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.7.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.8  Stress Ulcer

4.8.1   Current Trend and Analysis

4.8.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.8.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.9  Mouth Ulcers

4.9.1   Current Trend and Analysis

4.9.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.9.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.10 Venous Stasis Ulcers

4.10.1 Current Trend and Analysis

4.10.2 Market Size and Forecast, 2019 - 2028 ($ Billion)

4.10.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.11 Neuropathic Ulcers

4.11.1 Current Trend and Analysis

4.11.2 Market Size and Forecast, 2019 - 2028 ($ Billion)

4.11.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.12 Arterial Ulcers

4.12.1 Current Trend and Analysis

4.12.2 Market Size and Forecast, 2019 - 2028 ($ Billion)

4.12.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.13      Pressure Ulcers

4.13.1 Current Trend and Analysis

4.13.2 Market Size and Forecast, 2019 - 2028 ($ Billion)

4.13.3 Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Antiulcerant Drugs Market by Drug Type: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Proton Pump Inhibitors

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  H2 Receptor Antagonists

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.4  Gastric Mucosal Protective Drugs

5.4.1   Current Trend and Analysis

5.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.5  Antibiotics

5.5.1   Current Trend and Analysis

5.5.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.6  Antacids

5.6.1   Current Trend and Analysis

5.6.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.6.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.7  Prostaglandin Agonists

5.7.1   Current Trend and Analysis

5.7.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.7.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Antiuclerant Drugs Market by Geography: Market Size and Forecast, 2019 - 2028

6.1  Overview

6.1.1   Global Antiuclerant Market Year-on-Year Growth, by region 2020 – 2028 (%)

6.2  North America

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3   U.S.

6.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3.2        By Type

6.2.3.3        By Drug Type

6.2.4   Canada

6.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.4.2        By Type

6.2.4.3        By Drug Type

6.2.5   Mexico

6.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.5.2        By Type

6.2.5.3        By Drug Type

6.3    Europe

6.3.1   Current Trend and Analysis

6.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3   UK

6.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3.2        By Type

6.3.3.3        By Drug Type

6.3.4   Russia

6.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.4.2        By Type

6.3.4.3        By Drug Type

6.3.5   France

6.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.5.2        By Type

6.3.5.3        By Drug Type

6.3.6   Italy

6.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.6.2        By Type

6.3.6.3        By Drug Type

6.3.7   Germany

6.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.7.2        By Type

6.3.7.3        By Drug Type

6.3.8   Rest of Europe

6.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.8.2        By Typ

6.3.8.3        By Drug Type

6.4    Asia-Pacific

6.4.1   Current Trend and Analysis

6.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3   China

6.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3.2        By Type

6.4.3.3        By Drug Type

6.4.4   India

6.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.4.2        By Type

6.4.4.3        By Drug Type

6.4.5   Japan

6.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.5.2        By Type

6.4.5.3        By Drug Type

6.4.6   Rest of Asia-Pacific

6.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.6.2        By Type

6.4.6.3        By Drug Type

6.5    RoW

6.5.1   Current Trend and Analysis

6.5.2   Market Size and Forecast

6.5.3   South America

6.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.3.2        By Type

6.5.3.3        By Drug Type

6.5.4   Middle East

6.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.4.2        By Type

6.5.4.3        By Drug Type

6.5.5   Africa

6.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.5.2        By Type

6.5.5.3        By Drug Type 

Chapter 7        Company Profiles 

7.1  Astrazeneca Plc

7.1.1     Company Overview

7.1.2     Product Portfolio

7.1.3     Business Strategies

7.1.4     Financials

7.1.5     Recent Developments

7.2  Allergan Plc

7.2.1     Company Overview

7.2.2     Product Portfolio

7.2.3     Business Strategies

7.2.4     Financials

7.2.5     Recent Developments

7.3  Daewoong Pharmaceutical Co., Ltd.

7.3.1     Company Overview

7.3.2     Product Portfolio

7.3.3     Business Strategies

7.3.4     Financials

7.3.5     Recent Developments

7.4  Eisao Co. Ltd.

7.4.1     Company Overview

7.4.2     Product Portfolio

7.4.3     Business Strategies

7.4.4     Financials

7.4.5     Recent Developments

7.5  Takeda Pharmaceutical Company

7.5.1     Company Overview

7.5.2     Product Portfolio

7.5.3     Business Strategies

7.5.4     Financials

7.5.5     Recent Developments